CompletedNot Applicable

The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania

Tanzania2,584 participantsStarted 2018-04-01

Plain-language summary

This study aims to compare the burden of neurocysticercosis among people living with HIV to people not infected with HIV.

Who can participate

Age range

14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who consent to participate in the study and testing. * Patients of age 14 years and above * Patient living inside the study catchment area * HIV-positive patients * Patient suspected of taeniasis or cysticercosis/neurocysticercosis Exclusion Criteria: * Patients with opportunistic infections. * Study participants taking anthelminthic drugs PZQ and ALB or have received them within the previous 12 months. * Pregnant women * Patients that are seriously ill. * Patients with epilepsy and other mental disorders that impair thoughts and emotions such as psychosis.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Prevalence of cysticercosis

Timeframe: Single assessment at inclusion into study (serological testing)

Prevalence of neurocysticercosis

Timeframe: Single assessment through cerebral CT scan at inclusion into study

Trial details

NCT IDNCT03851419

SponsorTechnical University of Munich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-30

View on ClinicalTrials.gov More Neurocysticercosis trials

Who can participate

Age range

14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.